Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-03 09:14 am Purchase |
2025-02-24 | 13G | Bicara Therapeutics Inc. Common Stock BCAX |
FMR CORP | 2,803,807 5.200% |
686,719 (+32.44%) |
Filing History |
| 2025-02-12 09:16 am Sale |
2024-12-31 | 13G | Bicara Therapeutics Inc. Common Stock BCAX |
FMR CORP | 2,117,088 3.900% |
-378,245 (-15.16%) |
Filing History |
| 2024-09-26 4:30 pm Purchase |
2024-09-16 | 13G | Bicara Therapeutics Inc. Common Stock BCAX |
Invus Public Equities, L.P. | 3,072,827 5.700% |
3,072,827 (New Position) |
Filing History |
| 2024-09-26 4:16 pm Purchase |
2024-09-16 | 13G | Bicara Therapeutics Inc. Common Stock BCAX |
Red Tree GP, LLC | 3,170,509 5.800% |
3,170,509 (New Position) |
Filing History |
| 2024-09-23 4:17 pm Purchase |
2024-09-16 | 13D | Bicara Therapeutics Inc. Common Stock BCAX |
RA Capital Management, L.P. | 6,955,993 12.800% |
6,955,993 (New Position) |
Filing History |
| 2024-09-18 5:10 pm Purchase |
2024-09-16 | 13D | Bicara Therapeutics Inc. Common Stock BCAX |
TPG GP A, LLC | 3,010,425 5.500% |
3,010,425 (New Position) |
Filing History |
| 2024-09-18 11:57 am Purchase |
2024-09-18 | 13G | Bicara Therapeutics Inc. Common Stock BCAX |
FMR CORP | 2,495,333 5.095% |
2,495,333 (New Position) |
Filing History |